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scri~s of European Schnol of Oncololw Mo.ngPaphs that are 
intended to disseminate ~pidly the r,~ults of study group rn~ctinlP 
involving experts in th. field. 
As the title suggests, the book is mainly devoted to the clinical 
assets of tim intcrferons ~ anli.~necr agents, Two u~i'ul 
summary eltapters, by Woll and Crowther and by wagstafr, tmgin 
and end tl~ book. providing an overview of the clinic.l successes 
and failures of  interferon therapy, and looking to the future, 
respectively. Sandwiched bet~¢n thcs~ arc dot-ileal ~tccounts of 
th¢ uses of intcrfcrons in tim treatment of my¢lorrm. Iow-ilrad¢ 
lymphoma and neurocndocrine turnouts. 
Apart from a chapter by Stark on the molecular aspects of 
interferon production and =orion there is littl~ biochcmistw in this 
monogntph, and i detected some gcnenali~mtions h¢r¢ and there 
that could ndsiead re.uders unfamiliar with the field, Altltough the 
unti-prolifer.ttive eft'errs of interfcrons unfortunately arc easily 
d~'raonstratcd in tissue culture than they are ~vith pati¢nts, it is still 
an exaggeration to say that "a majority of turnout cell lille.s are 
growth inhibited by interferom in vitro', More :mriously, It 
distort¢d view of the poorly understood signal transduction 
pathways u~d by the interfetons could tm obtained from ~su~tl 
(and unreferenc~d)remarks, such as the su~lestion that th~ 
interferon-gamn'm receptor is O.protcin linked. Even Smrk*s 
chapter ignores it larllc body of evident* indicting the 
involven~nt of protein kimue C (or ~ similar type of protein 
kina~) in tim re|ul~tion of i~nc expression by tl~ a and .8 
interrcrons. 
Ofcounm, wcdo not need to know how an agent works in order 
to use it successfully in the clinic. Nevcrt~less. the future of 
interferon therapy probably l i~ in tim de-~clopmcnt of com- 
bination treatments, with other cytokincs or with chemo- 
thcra~utie drujls, zt theme th,tt crops up in smveral ptao:s, The 
reports of synergistic effects ~twccn different combinations of 
thctm a~nts mi~ important questions about the mechanisms 
responsible, and tiacsc will need to bc answered if a radonal 
approach is to be adopted in the future, As Well and Crowther 
state, the initial euphoria by t~ting the interfcrons as anti,caner 
agents in vitro and in rive has given way to cautious optimism 
born of mature r¢l~ction, As a biochemist, perhaps one must add 
that the future of this branch of medicine should lie in the 
acquisition of knowledge born of experiment, 
Mike Clemens 
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The two volume treatise on biochemical as~cts oF canexr 
research was designed to provide readers with ~tn insight into tile 
underlying biochemistry of selected cancers, Unlbrtunately this 
reviewer eceived only the first volume, and as such my comments 
are restricted to the contents ofvol, L It may well be that volume 
lI has yet to be published! in this regard it would have I~en 
inform:ttive if volume l g~ve some kind of indication as to the 
topics covered in volume II. 
Daring the last twenty years there has been an ¢xpon¢ntial 
growth in the publications of ean=r.orientated r search, making 
it almost impossible for the average r~carch scientist or clinician 
to keep in anyway abreast of the field, He or she has come to rely 
more and more on publications of the sort being reviewed herein 
to obtain a broad picture on the current status of research in areas 
as diver~ as drug resistance, oncogenes and turnout progression. 
This book brin~ tog¢th~r rcr~nt developments in the biochemical 
area of selected human cancers. The volum~ reviewed consists of 
13 chapters running to 444 pages with ea~h chapter well endowed 
with appropriate bibliographies, The topics covered range from 
oncogenes and turnout suppressor genes to tlte role of kinas:s and 
the cxtraeellular matrix in turnout development, Each chapter is 
contributed by an expert researcher in the field and is by and large 
w=ll sprinkled with informative diagrams, The initial chapter in 
the book examines the role played by turnout suppressor genes in 
human cancers, an area of research which is both exciting and 
rapidly expanding at prctmnt, An excellent subs~uent chapter by 
M. Oren looks in detail at wl'~tt we know about p53. the archetypal 
turnout suppressor cane, Other well-written chapters cover topics 
on chromosomal markers o1" caner and protein kinnse C in 
neoplastic cells, 
There arc a number of weaknesses and omissions in this volume, 
none of which are serious or worthy of comment except ~rhaps 
the level of detail which individual contributors go into op 0~eir 
• ~ubject. For example the chapter on illathatbione transferales by 
Sara and Tsuchida goes into considerable detail oti the 
biochemical structure and function of this enzyme with 19 pages 
of refereng, s. In contrast Ootte~man et al. give a much more 
general review on multi.drug resistanc~ with as few as 8 pag~s of 
references. This imbalance makes for difficult reading, and I ask 
myself at what kind of reader is the book targeted; the individual 
who wants a general overv':w or the cancer exl~rt who wants 
detailed praise information? It is dcbatabl~ whether these 
comments are really worthwhile criticisms, but in my opinion they 
do reflect a certain lack of editorial guidan~. The job of an editor 
is to ensure that each contributor is aware of the type of reader 
the book is aimed at and is given editorial guidelines that enable 
a readable well balanced volume to b¢ produced at the end of the 
day, However, having said all that, I feel that this volume is a good 
buy and well worth the $99,00 prigs tag, 
T.G. Cotter 
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